J1451 HCPCS Level II code: Injection, fomepizole, 15 mg
J1451 is the HCPCS code for “Injection, fomepizole, 15 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J1451Injection, fomepizole, 15 mg
Short description: Fomepizole, 15 mg
HCPCS · United States
Notes for J1451
As CMS prints them, with any note J1451 takes from the headings above it.
Note
- CMS processing note 0095: AS REQUIRED BY BBRA SECTION 201.
Medicare details
The indicators CMS publishes with J1451 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2006
Where J1451 sits
- 1J codesDrugs administered other than orally
- 2Active code J1451Injection, fomepizole, 15 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J1451 mean?
J1451 is the HCPCS code for “Injection, fomepizole, 15 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J1451?
CMS lists J1451’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J1451
All J codesJ1445Injection, ferric pyrophosphate citrate solution (triferic avnu), 0.1 mg of ironJ1446Injection, tbo-filgrastim, 5 microgramsJ1447Injection, tbo-filgrastim, 1 microgramJ1448Injection, trilaciclib, 1mgJ1449Injection, eflapegrastim-xnst, 0.1 mgJ1450Injection fluconazole, 200 mgJ1452Injection, fomivirsen sodium, intraocular, 1.65 mgJ1453Injection, fosaprepitant, 1 mgJ1454Injection, fosnetupitant 235 mg and palonosetron 0.25 mgJ1455Injection, foscarnet sodium, per 1000 mgJ1456Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mgJ1457Injection, gallium nitrate, 1 mg